Clinical Trial Update: Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for beta 3 agonists exploring treatment of voiding disorders and overactive bladder in children, currently in Phase 1/Phase 2 with unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Voiding Disorders

Drugs mentioned

• Beta 3 agonists

Snippet

Sponsor: Mansoura University | Conditions: Voiding Disorders, Overactive Bladder | Phase 1, Phase 2 | Status: UNKNOWN